Form 8-K, current report
Atrium Therapeutics, Inc., 8-K filed 2026-08-13
Published 13 Aug 2026 · retrieved 14 Aug 2026, 02:30 EDT · version 1Official source
The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.
Filing record
¶1
8-K filed with the Securities and Exchange Commission by Atrium Therapeutics, Inc. (CIK 0002093101) on 2026-08-13.
¶2
Accession number 0001193125-26-349482. EDGAR reports the filing package as 241 KB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/2093101/000119312526349482/0001193125-26-349482-index.htm.